Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Ra Pharmaceuticals Shares Up 100% Following $2.1 Billion Takeover Bid

Shares of Ra Pharmaceuticals doubled today after the firm announced that it will be acquired by Belgian firm UCB for $48 per share in an all cash deal. Prior to the market open this morning Ra Pharmaceuticals Inc. (RARX:NASDAQ) and Brussels-based UCB (UCB:Euronext)...
Streetwise Reports | October 11, 2019 |

Boston Scientific Reports 13% Q3 Sales Growth and Raises Yearly Estimates

This morning shares of Boston Scientific traded 6% higher after the firm reported a 13.1% increase in revenue for Q3/19. The firm also raised its revenue guidance for both Q4/19 and FY/19. Early this morning medical device maker Boston Scientific Corp. (BSX:NYSE) an...
Streetwise Reports | October 24, 2019 |

Buzz on the Bullboards: The Fast Movers & the Up-and-Comers

On Buzz on the Bullboards, we normally provide the Stockhouse Community with a snapshot of recent Bullboard activity, often accompanied by an Investor Pulse Poll – providing you with information on current sentiment. It has been generally difficult for energy companie...
Stockhouse Editorial | March 30, 2022 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |

Granite Creek Copper Plans Yukon Exploration as Copper Price Predicted to Rise

Granite Creek Copper (TSX.V: GCX ) Granite Creek President & In this exclusive interview, Tim Johnson, the President, Director, and CEO of Granite Creek Copper (part of the Metallic Group of Companies) sits down with Maurice Jac...
Maurice Jackson | December 13, 2019 |

The Rise of Silver and Major Economic Decline

After a period of economic prosperity, it is a given that eventually a period of economic decline will follow. This is a well known reality. Since at least the early 80s there has been a period of great economic prosperity. Yes, there were many recessions during that perio...
Hubert Moolman | June 14, 2019 |

After This Confirmation Gold Prices Will Rise Fast

A while ago, I wrote about a coming confirmation of the multi-year gold bull market. It has taken longer than expected, but that signal has now arrived, and the bull is very much confirmed. Here is a gold chart indicating that very important signal I have marked two...
Hubert Moolman | June 25, 2019 |

Can Gold Rise Without a Rate Cut?

Can Gold Rise Without a Rate Cut? The downside potential in precious metals discussed last week is playing out as Gold and gold stocks have broken down technically. The global economy appears to be firming and that is evidenced by a sustained rebound in global equity mar...
Jordan Roy-Byrne, CMT | April 23, 2019 |

Rise Gold Drills 90.4 g/t Gold over 4.7 Meters

Rise Gold was the subject of a piece by me back in early 2017. Anyone interested in the company should read the piece. The purchase by the company of the Idaho-Maryland gold mine for $2 million was an extraordinary deal for Rise. Rise just released the most interesti...
Streetwise Reports | March 21, 2019 |

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |
1 2 3 4 5 6 7 8 9 10 ...